CN102698043A - Medicinal combination for treating thyroid gland - Google Patents
Medicinal combination for treating thyroid gland Download PDFInfo
- Publication number
- CN102698043A CN102698043A CN2012101687977A CN201210168797A CN102698043A CN 102698043 A CN102698043 A CN 102698043A CN 2012101687977 A CN2012101687977 A CN 2012101687977A CN 201210168797 A CN201210168797 A CN 201210168797A CN 102698043 A CN102698043 A CN 102698043A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- thyroid
- medicinal combination
- thyroid gland
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a medicinal combination for treating thyroid gland. The combination consists of frankincense, myrrh, cutch, dragon bone, daemonorops draco, borneol, gardenia, forsythia, pseudo-ginseng, safflower, bitter orange, platycodon grandiflorum, scrophularia, cyathula root and tree peony bark. The medicinal combination provided by the invention is made into clinically acceptable tablets, capsules, granules, pills, powder, decoction or oral liquid by adding conventional auxiliary materials according to a conventional process. The medicinal combination provided by the invention has the efficacy of diminishing inflammation and invigorating blood circulation, can repair tissue cells and enhance immunomodulatory functions of human body tissues, and has remarkable effects on treating thyroid gland, goiter, hyperthyroidism, and thyroid functional impairment.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to the thyroid pharmaceutical composition of a kind of treatment.
Background technology
Thyroiditis is a kind of common thyroid disease, and the women sees more.Clinical manifestation is varied; Same type thyroiditis not only can show as hyperthyroidism at the different times of the course of disease; Also can show as hypothyroidism; Can show as diffusivity thyroid pathological changes, can also show as thyroid nodule, dissimilar sometimes thyroiditiss can be changed mutually.Therefore thyroiditis relates to the various aspects of thyroid disease, and needs and many thyroid diseases carry out Differential Diagnosis, and all kinds and the clinical characters of understanding thyroiditis are significant.
Summary of the invention
The object of the invention is to provide a kind of treatment thyroid pharmaceutical composition.
The present invention realizes through following technical scheme:
The crude drug of pharmaceutical composition of the present invention consists of:
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Pharmaceutical composition of the present invention adds conventional adjuvant according to common process and processes the tablet of clinical acceptance, capsule, granule, pill, powder, decoction or oral liquid.
Pharmaceutical composition of the present invention has the effect that antiinflammatory is invigorated blood circulation, and ability repair tissue cell strengthens the when injected organism tissue immunoloregulation function.Remarkable to treatment thyroiditis, goiter and hyperthyroidism, the thyroid function property effect that goes down.
Following experimental example is used to further specify the present invention, but is not limited to the present invention.
One, experimental example clinical trial
1, clinical observation
Pill of the present invention (according to embodiment 1 method preparation), treatment thyroiditis, goiter and hyperthyroidism, thyroid function property patient's 60 examples that go down, male's 10 examples wherein, women's 50 examples, age 10-60 year.
2, Therapeutic Method
Pill of the present invention (according to the preparation of embodiment 1 method), every day 2-3 time, each 2-4 grain.Took 60 days.
3, diagnostic criteria
The slow thyromegaly of development, nodosity matter tough person should suspect, the typical clinical performance is arranged, as long as TMA, the TGA positive are diagnosable; During its atypical clinical manifestations, high titre TMA, TGA could diagnose, and promptly two antibody are put the method for exempting from continuous 2 times>60%; When hyperthyroidism was arranged, high titre antibody was worked as clinical signs of suspected more than lasting half a year; Negative antibody or not high, but value is made a definite diagnosis in aspiration biopsy in case of necessity.
4, criterion of therapeutical effect
Produce effects: blood examination each item index is normal;
Effectively: blood examination each item index is normal basically;
Invalid: blood examination each item index no change.
5, therapeutic outcome
Disease | The treatment number | Produce effects | Effectively | Invalid | Total effective rate |
Thyroid | 60 examples | 50 | 7 | 3 | 95% |
6, conclusion
60 routine patients took pill of the present invention (according to the preparation of embodiment 1 method) respectively 60 days, and the result shows that the present invention treats 60 examples, and total effective rate is 95%.
Experimental example two, model case
Case 1, king XX, the woman, 8 years old, Mays 28 in 2009, the chemical examination of Nikkei Yuncheng examination in hospital was diagnosed as thyroiditis, goiter, and 2 months curative effects of western medicine are not remarkable, take pill of the present invention and (prepare every day 2-3 time, each 2-4 grain according to embodiment 1 method.) blood examination each item index was normal basically in back 10 days, recovery from illness after 45 days.
Case 2, Liu XX, woman; 46 years old, be diagnosed as hyperthyroidism on July 22nd, 2009, western medicine recurred after 1 year; Day unsatisfactory curative effect surplus Shijiazhuang City hospital hospitalization 20, blood examination each item index was normal basically in back 45 days to take capsule of the present invention (according to the preparation of embodiment 2 methods), recovery from illness after 120 days.
Case 3; Zhao XX, woman, 28 years old; Augusts 28 in 2009, the chemical examination of Nikkei Yuncheng examination in hospital was diagnosed as thyroiditis, goiter; Western medicine 3 wheat harvesting period curative effects are not remarkable, take tablet of the present invention (according to embodiment 3 methods preparations) medicine after 21 days blood examination each item indexs normal basically, recovery from illness after 95 days.
Case 4; Merchant XX, woman, 38 years old; JIUYUE 22 in 2009, the chemical examination of Nikkei Yuncheng examination in hospital was diagnosed as thyroiditis, goiter; 3 months curative effects of western medicine are not remarkable, and blood examination each item index was normal basically in back 30 days to take granule of the present invention (according to the preparation of embodiment 4 methods), recovery from illness after 120 days.
Following embodiment all can realize the effect of above-mentioned experimental example.
Embodiment 1 pill
Said medicine adds conventional adjuvant according to common process and processes pill.Every day 2-3 time, each 2-4 grain.
Embodiment 2 capsules
Said medicine is added conventional adjuvant according to common process process capsule.
Embodiment 3 tablets
Said medicine is added conventional adjuvant according to common process process tablet.
Embodiment 4 granules
Said medicine is added conventional adjuvant according to common process process granule.
Embodiment 5 oral liquids
Said medicine is added conventional adjuvant according to common process process oral liquid.
Embodiment 6 powders
Said medicine is added conventional adjuvant according to common process process powder.
Claims (7)
5. like the described pharmaceutical composition of one of claim 1-4, it is characterized in that said composition adds conventional adjuvant according to common process and processes the tablet of clinical acceptance, capsule, granule, pill, powder, decoction or oral liquid.
6. like the application of the described pharmaceutical composition of one of claim 1-4 in the thyroid medicine of preparation treatment.
7. the application of drug regimen as claimed in claim 6 is characterized in that said thyroid is meant that thyroiditis, goiter, hyperthyroidism and thyroid function property go down.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101687977A CN102698043B (en) | 2012-05-28 | 2012-05-28 | Medicinal combination for treating thyroid gland |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101687977A CN102698043B (en) | 2012-05-28 | 2012-05-28 | Medicinal combination for treating thyroid gland |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102698043A true CN102698043A (en) | 2012-10-03 |
CN102698043B CN102698043B (en) | 2013-09-04 |
Family
ID=46891290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101687977A Expired - Fee Related CN102698043B (en) | 2012-05-28 | 2012-05-28 | Medicinal combination for treating thyroid gland |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102698043B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103432476A (en) * | 2013-08-17 | 2013-12-11 | 广州市云桥生物科技有限公司 | Composition consisting of effective traditional Chinese medicine parts and used for treating hyperthyroidism |
CN105288166A (en) * | 2015-12-02 | 2016-02-03 | 青岛市中心医院 | Traditional Chinese medicine composition for thyroid enlargement and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1238970A (en) * | 1998-06-12 | 1999-12-22 | 许世平 | 'Jiakangkangfu' table for curing thyroidism |
-
2012
- 2012-05-28 CN CN2012101687977A patent/CN102698043B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1238970A (en) * | 1998-06-12 | 1999-12-22 | 许世平 | 'Jiakangkangfu' table for curing thyroidism |
Non-Patent Citations (3)
Title |
---|
冯利: "甲状腺功能亢进症的研究概况与展望", 《中医药研究》 * |
王旭: "益气消瘿汤治疗甲状腺功能亢进症临床观察", 《山东中医杂志》 * |
邢一伟: "辨证治疗甲状腺机能亢进", 《吉林中医药》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103432476A (en) * | 2013-08-17 | 2013-12-11 | 广州市云桥生物科技有限公司 | Composition consisting of effective traditional Chinese medicine parts and used for treating hyperthyroidism |
CN103432476B (en) * | 2013-08-17 | 2015-04-15 | 张群 | Composition consisting of effective traditional Chinese medicine parts and used for treating hyperthyroidism |
CN105288166A (en) * | 2015-12-02 | 2016-02-03 | 青岛市中心医院 | Traditional Chinese medicine composition for thyroid enlargement and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102698043B (en) | 2013-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463539B (en) | A kind of medicine for the treatment of eczema and its production and use | |
CN102008650B (en) | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof | |
CN101491663A (en) | Traditional Chinese medicine composition for treating various cancer | |
CN106334060B (en) | Pharmaceutical composition for treating obesity type polycystic ovarian syndrome | |
CN102755600B (en) | Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence, preparation method and uses | |
CN102698043B (en) | Medicinal combination for treating thyroid gland | |
CN103768357B (en) | A kind of Traditional Chinese medicine compound composition with treatment recurrent aphtha | |
CN102370795B (en) | Self-heated traditional Chinese medicine (TCM) emplastrum for treating primary dysmenorrhea | |
CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
CN101693084B (en) | Medical composition for treating epigastric pain yin deficiency syndrome and preparation method thereof | |
CN101849983B (en) | Medicament for treating eczema | |
CN104225036B (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating urinary system infection | |
CN101085113A (en) | Traditional Chinese medicine preparation for treating AIDS | |
CN102274336B (en) | Medicine composition for treating rheumatoid arthritis | |
CN104547851B (en) | One treats hypertensive medicine | |
CN109125427B (en) | Penyanjing suppository and preparation method thereof | |
CN103800736A (en) | Pharmaceutical composition for treating hypertensive nephrosclerosis and application of pharmaceutical composition | |
CN106668240A (en) | Pharmaceutical composition for treating vitreous opacity | |
CN104225034B (en) | Application of composition in preparing medicine for treating non-infectious urethral syndrome | |
CN103536745A (en) | Traditional Chinese medicinal watered pills for treating hyperplasia of mammary glands | |
CN111888448B (en) | Traditional Chinese medicine composition for treating psoriasis | |
CN102266482B (en) | Medicament for treating mania | |
CN107080817A (en) | A kind of Novel gynecology-department a thousand pieces of gold oil of zedoary turmeric bolt | |
CN105770817A (en) | Qi-tonifying, blood-activating, dehumidifying and detoxifying different-skin-disease-treating traditional-Chinese-medicine composition formula | |
CN105663577A (en) | Traditional Chinese medicine composition for postpartum care and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130904 Termination date: 20140528 |